ADMA Biologics, Inc.

Virology-focused Enanta Pharmaceuticals, Inc. took a positive step in its two-mechanism approach to providing a treatment for respiratory syncytial virus (RSV) on 26 September as its RSV L-protein i

Follow-on public offerings (FOPOs) have become increasingly difficult to execute in the current financial market climate with public biopharmaceutical company valuations plummeting, so many drug devel

Four biopharmaceutical companies saw an opening in the US stock market for new offerings and seized the opportunity before the window could shut again, launching an initial public offering, two follow

Five out of six biopharmaceutical companies that have launched initial public offerings in the US this year closed higher on their first day of trading, with one – Black Diamond Therapeutics Inc. –